The widespread adoption of weight-loss medications, such as Ozempic and Wegovy, is poised to trigger a significant transformation in global consumption patterns, according to marketer Jahnavi Jain. She argues that these drugs will not only change what people eat but also influence purchasing decisions across several sectors, from beauty products to beverages.
Current Impact and Future Projections
Currently, approximately one in eight Americans uses Ozempic or Wegovy. Jain projects that by 2030, households using these medications could account for a substantial 35 percent of all food and beverage spending. Early indicators already show a shift, with snacking declining by 40-60 percent among users, restaurant dinner traffic falling by 6 percent, and overall grocery spending dropping by 31 percent.
The impending launch of oral pill versions of these drugs is expected to dramatically accelerate their adoption. Jain notes that while some consumers may be hesitant about injectable medications, a pill format will likely see an “explosion” in usage, making these shifts even more pronounced.
Industries Poised for Change
Jain detailed several key areas where consumption patterns are set to evolve:
- Meals: Consumers will increasingly favor high-protein, nutrient-dense mini-meals, emphasizing quality over quantity. Food companies are already adapting; Nestle, for instance, has launched a new brand specifically targeting this consumer segment.
- Skincare: Rapid weight loss can lead to issues like skin laxity, hair thinning, and accelerated aging. This will drive demand for specialized skincare products focusing on skin firming and collagen production.
- Beverages: There will be a notable decline in the consumption of sugary drinks. Instead, consumers will opt for nutritional supplements like electrolyte drinks, protein-enhanced water, and gut-health shots, making hydration a more “medical” choice.
- Premium Indulgence: While daily expenditures on junk food may decrease, consumers will likely be willing to spend more on high-quality, premium treats, valuing exceptional indulgence over frequent, lower-quality options.
Businesses Facing Challenges
Conversely, certain industries are expected to face headwinds due to these changing habits:
- Snacking: The market for readily available, often unhealthy, snack foods like chips and cookies will likely shrink.
- Fast Food: Fast food chains are already seeing declining traffic, a trend expected to worsen.
- Sugary Drinks: Popular beverages laden with sugar will continue to lose favor.
- Large Meals: Traditional platters and thalis offering large, carb-heavy meals may need to adapt their portion sizes and nutritional profiles.
The India Context
While mass adoption in India may take longer than in the US, Jain suggests that premium urban consumers in metropolitan areas—those who are early adopters of lifestyle trends—will be the first to embrace GLP-1 drugs. If prices become more accessible, this segment could adopt these medications within two years. Brands targeting these consumers must anticipate a significant reduction in appetite (up to 30 percent) and a stronger preference for quality over quantity in all purchases. Although a smaller segment today, these early adopters often set trends for the broader market within 3-5 years.